http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1136080-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6506cf133be42545d51d1490056f6af |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 |
| filingDate | 1965-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd0d4972560f266b46e06f61877a88f0 |
| publicationDate | 1968-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1136080-A |
| titleOfInvention | Pharmaceutical compositions |
| abstract | 1,136,080. 3-ethyl salicyclic acid; steroids. ASPRO-NICHOLAS Ltd. 13 April, 1966 [14 April, 1965], No. 15959/65. Heading A5B. Pharmaceutical compositions having antiinflammatory, anti-hypercholesterolaemic and/ or choleretic activities comprise a 3-ethylsalicylic acid compound and optionally an antiinflammatory corticosteroid or an anti-hypercholesterolaemic steroid. The anti-inflammatory steroid may be prednisone, prednisone acetate, prednisolone, prednisolone acetate, hydrocortisone alcohol or acetate, dexamethasone or triamcinolone and the anti-hyper cholesterolaemic steroid may be androsterone 'or the acetate or propionate thereof or #-sitosterol. The 3- ethylsalicylic acid compound may comprise 3-ethylsalicylic acid or pharmacologically useful salts thereof e.g. Na, K, Ca, Al and Mg salts; or esters thereof e.g. the ethyl ester. The compositions may be administered orally or rectally in form of tablets, capsules, suppositories, cachets or suspensions containing conventional diluents or carriers. |
| priorityDate | 1965-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.